[LABP] YoY Quarter Result on 30-Jun-2021 [#Q2]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
29-Jul-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- 141.73%
YoY- 185.77%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 0 0 18,000 0 -
PBT -3,922 -11,284 4,097 -4,777 -6.36%
Tax -557 18 -174 -311 21.44%
NP -3,922 -11,302 4,097 -4,777 -6.36%
Tax Rate - - 4.25% - -
Total Cost 3,922 11,302 13,903 4,777 -6.36%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin 0.00 0.00 22.76 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.63 -2.81 1.20 -1.46 -24.43%
EPS Diluted -0.63 -2.81 1.20 -1.46 -24.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.